Eric Francois
CIK 1656125 · Chief Financial Officer · last filed 2026-04-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$49.6K
Companies
3
Total Filings
13
Lifetime Open-Market Net
$49.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted | Director | — | $0.05 | — | $0 | 1 | 2026-04-21 |
| CervoMed Inc. (DFFN) Delisted | Director | — | $6.60 | — | $0 | 1 | 2021-07-06 |
| SCYX | Chief Financial Officer | 11,732 | $4.23 | $49.6K | $49.6K | 11 | 2021-02-02 |
Recent Filings · Page 2 of 2
13 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-06-28 | SCYX | Buy (P) | +15,000 | $35.9K | EDGAR |
| 2016-04-05 | SCYX | Grant (A) | — | $0 | EDGAR |
| 2015-11-03 | SCYX | Grant (A) | — | $0 | EDGAR |
Showing 11–13 of 13
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.